Does GEMTUZUMAB OZOGAMICIN Cause Hepatic function abnormal? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Hepatic function abnormal have been filed in association with GEMTUZUMAB OZOGAMICIN (Mylotarg). This represents 0.7% of all adverse event reports for GEMTUZUMAB OZOGAMICIN.
12
Reports of Hepatic function abnormal with GEMTUZUMAB OZOGAMICIN
0.7%
of all GEMTUZUMAB OZOGAMICIN reports
7
Deaths
7
Hospitalizations
How Dangerous Is Hepatic function abnormal From GEMTUZUMAB OZOGAMICIN?
Of the 12 reports, 7 (58.3%) resulted in death, 7 (58.3%) required hospitalization.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMTUZUMAB OZOGAMICIN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does GEMTUZUMAB OZOGAMICIN Cause?
Febrile neutropenia (412)
Pyrexia (138)
Sepsis (122)
Thrombocytopenia (117)
Venoocclusive liver disease (117)
Off label use (88)
Drug ineffective (87)
Death (81)
Bone marrow failure (80)
Neutropenia (68)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which GEMTUZUMAB OZOGAMICIN Alternatives Have Lower Hepatic function abnormal Risk?
GEMTUZUMAB OZOGAMICIN vs GEMZAR
GEMTUZUMAB OZOGAMICIN vs GENTAMICIN
GEMTUZUMAB OZOGAMICIN vs GEODON
GEMTUZUMAB OZOGAMICIN vs GILENYA
GEMTUZUMAB OZOGAMICIN vs GILOTRIF